After a year of stripping back its head count and pipeline, Carisma Therapeutics is now cutting down to the bone and laying ...

Target enrollment exceeded with 1009 patients randomized in the main cohort and 410 patients in the exploratory cohort ...

Nearly 90 per cent of longevity clinics worldwide provide treatments influenced more by marketing than by scientific evidence ...

New REVEAL-1 study results show early signs of weight maintenance after GLP-1 discontinuation REMAIN-1 pivotal study now more ...

China NMPA grants breakthrough therapy designation for Innovent’s PD-1/IL-2a-bias bispecific antibody fusion protein, IBI363 in melanoma: San Francisco, US Tuesday, April 1, 202 ...

A medical manufacturing company has opened a new facility in North Charleston to build autoinjectors. Swiss-based SHL Medical ...

SHL Medical, a global leader in the design, development, and manufacturing of advanced self-injection solutions, has ...

The transformation of healthy cells into invasive colorectal tumors is an extraordinarily complex process involving numerous ...

Learn more about whether Corcept Therapeutics Incorporated or Novartis AG is a better investment based on AAII's A+ Investor ...

This investigational treatment was generally well tolerated with no serious adverse events; fewer adverse events related to non-motor symptoms were reported in the solengepras arm Pivotal Phase 3 ...

Learn about the 4 essential types of diabetes, their unique characteristics, risk factors, and management strategies to ...

Researchers laid out nutritional management strategies for clinicians to offer patients before and after bariatric surgery to ...